Press Releases

Jun 17, 2024
SIGA Announces Agreement to Sell TPOXX® to ASEAN Member States
Further Advances SIGA’s Strategy to Expand Access to TPOXX into More International Markets NEW YORK , June 17, 2024 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. , a commercial-stage pharmaceutical company focused on global health and infectious diseases, announced today an agreement to expand access
May 07, 2024
SIGA Reports Financial Results for Three Months Ended March 31, 2024
Generated Product Sales of $24 Million and Pre-tax Operating Income of $11 Million Corporate Update Conference Call Today at 4:30 PM ET NEW YORK , May 07, 2024 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company, today reported financial
Mar 25, 2024
SIGA Names Larry Miller General Counsel
NEW YORK , March 25, 2024 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on health security and infectious diseases, announced the appointment of Larry Miller as general counsel, effective today.
Mar 12, 2024
SIGA Declares Special Cash Dividend of $0.60 Per Share
Represents a $0.15 Per Share Increase Over 2023 Special Dividend NEW YORK , March 12, 2024 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company, today announced that its board of directors declared a special cash dividend of $0.60 per share on